| Dr Matthew A Dugard, MD | |
|
17772 Beach Blvd, Huntington Beach, CA 92647-6819 | |
| (714) 842-1473 | |
| Not Available |
| Full Name | Dr Matthew A Dugard |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 31 Years |
| Location | 17772 Beach Blvd, Huntington Beach, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700911070 | NPI | - | NPPES |
| 00G809120 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G80912 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital Of Gardena | Gardena, CA | Hospital |
| Huntington Beach Hospital | Huntington beach, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beach Emergency Medical Associates | 8123120078 | 14 |
| Redondo Emergency Physicians Inc | 9032388269 | 15 |
News Archive
Hemophilia A patients who require high doses of Helixate® FS, Antihemophilic Factor (Recombinant), can now benefit from greater convenience in administering their treatment, thanks to a new 3000 IU (international unit) dosage strength. CSL Behring announced today that this new dosage strength is available in the U.S., allowing many patients to reduce reconstitution time by eliminating the need to mix and pool multiple vials of Helixate FS.
Taro Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. announced today that they have mutually agreed to terminate their merger agreement, announced in August 2012, pursuant to which all shareholders of Taro would have received a cash payment of $39.50 per share upon the closing of the merger.
Viruses have their own genetic material and can infect human cells in a very specific manner. They will then reproduce as directed by their own genes but using the resources of the host cell.
A viral infection in a pregnant woman not only affects her subsequent ability to provide maternal care but can also trigger depression in her offspring, which can then even extend into the next generation as a result of changes to genetic mechanisms in the brain.
› Verified 7 days ago
| Entity Name | Beach Emergency Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013074996 PECOS PAC ID: 8123120078 Enrollment ID: O20070222000661 |
News Archive
Hemophilia A patients who require high doses of Helixate® FS, Antihemophilic Factor (Recombinant), can now benefit from greater convenience in administering their treatment, thanks to a new 3000 IU (international unit) dosage strength. CSL Behring announced today that this new dosage strength is available in the U.S., allowing many patients to reduce reconstitution time by eliminating the need to mix and pool multiple vials of Helixate FS.
Taro Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. announced today that they have mutually agreed to terminate their merger agreement, announced in August 2012, pursuant to which all shareholders of Taro would have received a cash payment of $39.50 per share upon the closing of the merger.
Viruses have their own genetic material and can infect human cells in a very specific manner. They will then reproduce as directed by their own genes but using the resources of the host cell.
A viral infection in a pregnant woman not only affects her subsequent ability to provide maternal care but can also trigger depression in her offspring, which can then even extend into the next generation as a result of changes to genetic mechanisms in the brain.
› Verified 7 days ago
| Entity Name | Redondo Emergency Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376834937 PECOS PAC ID: 9032388269 Enrollment ID: O20110804000471 |
News Archive
Hemophilia A patients who require high doses of Helixate® FS, Antihemophilic Factor (Recombinant), can now benefit from greater convenience in administering their treatment, thanks to a new 3000 IU (international unit) dosage strength. CSL Behring announced today that this new dosage strength is available in the U.S., allowing many patients to reduce reconstitution time by eliminating the need to mix and pool multiple vials of Helixate FS.
Taro Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. announced today that they have mutually agreed to terminate their merger agreement, announced in August 2012, pursuant to which all shareholders of Taro would have received a cash payment of $39.50 per share upon the closing of the merger.
Viruses have their own genetic material and can infect human cells in a very specific manner. They will then reproduce as directed by their own genes but using the resources of the host cell.
A viral infection in a pregnant woman not only affects her subsequent ability to provide maternal care but can also trigger depression in her offspring, which can then even extend into the next generation as a result of changes to genetic mechanisms in the brain.
› Verified 7 days ago
| Entity Name | Telemedicine365, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912525817 PECOS PAC ID: 0648683920 Enrollment ID: O20210105001789 |
News Archive
Hemophilia A patients who require high doses of Helixate® FS, Antihemophilic Factor (Recombinant), can now benefit from greater convenience in administering their treatment, thanks to a new 3000 IU (international unit) dosage strength. CSL Behring announced today that this new dosage strength is available in the U.S., allowing many patients to reduce reconstitution time by eliminating the need to mix and pool multiple vials of Helixate FS.
Taro Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. announced today that they have mutually agreed to terminate their merger agreement, announced in August 2012, pursuant to which all shareholders of Taro would have received a cash payment of $39.50 per share upon the closing of the merger.
Viruses have their own genetic material and can infect human cells in a very specific manner. They will then reproduce as directed by their own genes but using the resources of the host cell.
A viral infection in a pregnant woman not only affects her subsequent ability to provide maternal care but can also trigger depression in her offspring, which can then even extend into the next generation as a result of changes to genetic mechanisms in the brain.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew A Dugard, MD Po Box 660519, Arcadia, CA 91066-0519 Ph: (626) 447-0296 | Dr Matthew A Dugard, MD 17772 Beach Blvd, Huntington Beach, CA 92647-6819 Ph: (714) 842-1473 |
News Archive
Hemophilia A patients who require high doses of Helixate® FS, Antihemophilic Factor (Recombinant), can now benefit from greater convenience in administering their treatment, thanks to a new 3000 IU (international unit) dosage strength. CSL Behring announced today that this new dosage strength is available in the U.S., allowing many patients to reduce reconstitution time by eliminating the need to mix and pool multiple vials of Helixate FS.
Taro Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. announced today that they have mutually agreed to terminate their merger agreement, announced in August 2012, pursuant to which all shareholders of Taro would have received a cash payment of $39.50 per share upon the closing of the merger.
Viruses have their own genetic material and can infect human cells in a very specific manner. They will then reproduce as directed by their own genes but using the resources of the host cell.
A viral infection in a pregnant woman not only affects her subsequent ability to provide maternal care but can also trigger depression in her offspring, which can then even extend into the next generation as a result of changes to genetic mechanisms in the brain.
› Verified 7 days ago
Kelly Flannigan Unger, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 17772 Beach Blvd, Huntington Beach, CA 92647 Phone: 714-843-5011 | |
Mr. Stanley Wayne Combs, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 16761 Edgewater Lane, Huntington Beach, CA 92649 Phone: 714-846-9400 | |
Charles B Obrien, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 21391 Pinetree Ln, Huntington Beach, CA 92646 Phone: 714-335-9024 | |
Dr. Patrick D Cichon, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8252 Lambert Dr, Huntington Beach, CA 92647 Phone: 323-363-3442 | |
Vince Truong, D.O. Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 7834 Glencoe Ave, Huntington Beach, CA 92647 Phone: 586-212-3164 Fax: 310-379-4856 | |
Jessica Rendin, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 17772 Beach Blvd, Huntington Beach, CA 92647 Phone: 714-843-5011 | |
Khanh Tran, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 17772 Beach Blvd, Huntington Beach, CA 92647 Phone: 714-842-1473 |